Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EPM2A anticorps (AA 243-331)

EPM2A Reactivité: Humain WB, EIA Hôte: Souris Monoclonal k2A3 unconjugated
N° du produit ABIN336090
  • Antigène Voir toutes EPM2A Anticorps
    EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
    Épitope
    • 13
    • 10
    • 10
    • 8
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 243-331
    Reactivité
    • 48
    • 8
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    Humain
    Hôte
    • 39
    • 8
    • 2
    Souris
    Clonalité
    • 43
    • 6
    Monoclonal
    Conjugué
    • 29
    • 5
    • 5
    • 4
    • 3
    • 3
    Cet anticorp EPM2A est non-conjugé
    Application
    • 37
    • 30
    • 28
    • 6
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Enzyme Immunoassay (EIA)
    Specificité
    The antibody recognizes EPM2A.
    Réactivité croisée (Details)
    Species reactivity (tested):Human
    Attributs du produit
    Synonyms: EPM2A, Laforin, EC=3.1.3.48, EC=3.1.3.16, Lafora PTPase, LAFPTPase
    Purification
    Protein-G affinity chromatography
    Immunogène
    Recombinant human EPM2A (aa 243-331) purified from E. coli
    Clone
    K2A3
    Isotype
    IgG1
    Top Product
    Discover our top product EPM2A Anticorps primaire
  • Indications d'application
    ELISA. Western blot (1: 1,000 - 1: 2,000).
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1.0 mg/mL
    Buffer
    PBS, pH 7.4, containing 0.09 % sodium azide
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    Store the antibody undiluted at 2-8 °C for up to two weeks or (in aliquots) at -20 °C forlonger. Avoid repeated freezing and thawing.
    Shelf life: one year from despatch.
    Date de péremption
    12 months
  • Antigène
    EPM2A (Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A))
    Autre désignation
    Laforin (EPM2A Produits)
    Synonymes
    anticorps TG-B, anticorps Tg(TcraK,TcrbK)TG-BFlv, anticorps EPM2, anticorps MELF, anticorps laforin, anticorps EPM2A, laforin glucan phosphatase, anticorps epilepsy, progressive myoclonic epilepsy, type 2 gene alpha, anticorps EPM2A, anticorps Epm2a
    Sujet
    Epilepsy, progressive myoclonus type 2A (EPM2A), also known as laforin, is a dual-specificity phosphatase that associates with polyribosomes. The protein may be involved in the control of glycogen metabolism, particularly in monitoring for and preventing the formation of poorly branched glycogen molecules. Defects in EPM2A are a cause of progressive myoclonic epilepsy type 2(EPM2), also known as Lafora disease. EPM2 is an autosomal recessive and severe form of adolescent-onset progressive epilepsy.Synonyms: EC=3.1.3.16, EC=3.1.3.48, EPM2A, LAFPTPase, Lafora PTPase, Laforin
    ID gène
    7957
    UniProt
    O95278
    Pathways
    Cellular Glucan Metabolic Process
Vous êtes ici:
Support technique